Seer (SEER) Cash from Investing Activities (2020 - 2026)
Seer (SEER) recorded quarterly Cash from Investing Activities of $18.1 million in Q1 2026, up 39.3% quarter-over-quarter from $13.0 million in Q4 2025, and down 26.55% on a YoY basis from $24.6 million in Q1 2025.
Seer (SEER) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Seer's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $18.1 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 26.55% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $55.0 million (down 5.34% YoY), while the FY2025 annual figure was $61.5 million, down 6.54% from the prior year.
- Cash from Investing Activities was $18.1 million for Q1 2026 at Seer, up from $13.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $32.4 million in Q1 2024 to a low of -$133.2 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged $3.6 million across 5 years, with a median of $13.0 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 350.0% in 2023, then jumped 570.03% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$2.7 million in 2022, then jumped by 325.41% to $6.1 million in 2023, then surged by 159.3% to $15.8 million in 2024, then dropped by 18.11% to $13.0 million in 2025, then jumped by 39.3% to $18.1 million in 2026.
- The last three Cash from Investing Activities figures came in at $18.1 million (Q1 2026), $13.0 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 579,519.10 |
| 10 | Seer | 96.59 Mn | 96.59 Mn | 982,000.00 | 18.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.08 Mn |
| Mar 31, 2026 | 18.08 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Mar 31, 2025 | 24.61 Mn |
| Mar 31, 2025 | 24.61 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 26.44 Mn |
| Sep 30, 2024 | 26.44 Mn |
| Jun 30, 2024 | -8.78 Mn |
| Jun 30, 2024 | -8.78 Mn |
| Mar 31, 2024 | 32.36 Mn |
| Mar 31, 2024 | 32.36 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Dec 31, 2023 | 6.11 Mn |